January 2019 – Page 129

Stealth BioTherapeutics: At Phase 3 Of Development, But Very Risky – Stealth BioTherapeutics (Pending:MITO)

January 9, 2019 admin 0

With one product candidate at Phase 3 of development and three product candidates at Phase 2 of development, Stealth BioTherapeutics (MITO) seems very tempting. Having said that, the financial risk is quite elevated. Stealth BioTherapeutics […]

Crude Oil, Gold Prices Focused on FOMC Meeting Minutes

January 9, 2019 admin 0

CRUDE OIL & GOLD TALKING POINTS: Crude oil prices rise with stocks on US-China trade war deal hopes Gold prices fall as yields rise in risk-on trade, tarnishing its appeal December FOMC meeting minutes, EIA […]